Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Protagonist Therapeutics, Inc (PTGX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
1 Mar 2024
PATEL DINESH V PH D
President and CEO, Director, Officer
Protagonist Therapeutics, Inc
(PTGX)
574,590
-4%
30,000
$31.62
$948,600.00
SELL
1 Mar 2024
Waddill William D.
Director
Protagonist Therapeutics, Inc
(PTGX)
12,000
-51%
12,975
$31.34
$406,636.50
SELL
29 Feb 2024
Ali Asif
Chief Financial Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
40,645
-37%
24,187
$31.60
$764,365.40
SELL
9 Jan 2024
Gupta Suneel
Chief Development Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
187,567
-2%
5,000
$25.00
$125,000.00
SELL
13 Dec 2023
PATEL DINESH V PH D
President and CEO, Director, Officer
Protagonist Therapeutics, Inc
(PTGX)
534,347
-12%
75,000
$20.08
$1,506,000.00
SELL
15 Nov 2023
MOLINA ARTURO MD
Chief Medical Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
22,527
-7%
1,848
$16.24
$30,011.52
SELL
21 Dec 2021
PATEL DINESH V PH D
President and CEO, Director, Officer
Protagonist Therapeutics, Inc
(PTGX)
477,158
-3%
15,000
$32.14
$482,170.50
SELL
17 Aug 2021
Liu David Y
Chief Scientific Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
58,254
-20%
14,779
$47.56
$702,889.25
SELL
10 Feb 2021
Noonberg Sarah B.
Director
Protagonist Therapeutics, Inc
(PTGX)
0
-100%
8,400
$25.30
$212,555.00
SELL
19 Jan 2021
PATEL DINESH V PH D
President and CEO, Director, Officer
Protagonist Therapeutics, Inc
(PTGX)
426,144
-5%
24,846
$24.60
$611,104.75
SELL
11 Aug 2020
KHOSLA CHAITAN PHD
Director
Protagonist Therapeutics, Inc
(PTGX)
0
-100%
2,499
$17.19
$42,952.06
BUY
12 Mar 2020
SELICK HAROLD E
Director
Protagonist Therapeutics, Inc
(PTGX)
15,310
+362%
12,000
$6.70
$80,400.00
BUY
3 Dec 2019
PATEL DINESH V PH D
President and CEO, Director, Officer
Protagonist Therapeutics, Inc
(PTGX)
389,824
+8%
30,000
$5.62
$168,500.00
BUY
3 Dec 2019
Giraudo Bryan
Director
Protagonist Therapeutics, Inc
(PTGX)
8,000
+100%
8,000
$5.70
$45,620.00
BUY
3 Dec 2019
Gupta Suneel
EVP Clinical Operations, Officer
Protagonist Therapeutics, Inc
(PTGX)
49,500
+153%
30,000
$5.13
$153,900.00
BUY
3 Dec 2019
Kalkofen Donald A.
Chief Financial Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
613
+209%
1,175
$5.10
$5,986.88
SELL
6 Aug 2019
PATEL DINESH V PH D
President and CEO, Director, Officer
Protagonist Therapeutics, Inc
(PTGX)
374,792
-2%
10,792
$8.85
$95,535.10
SELL
6 Aug 2019
Liu David Y
Chief Scientific Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
49,802
-6%
3,395
$8.85
$30,044.05
SELL
28 Feb 2019
Shames Richard S.
Chief Medical Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
32,021
-2%
657
$8.03
$5,275.71
SELL
28 Feb 2019
PATEL DINESH V PH D
President and CEO, Director, Officer
Protagonist Therapeutics, Inc
(PTGX)
383,831
-0%
2,183
$8.03
$17,529.49
SELL
28 Feb 2019
Liu David Y
Chief Scientific Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
51,197
-1%
810
$8.03
$6,504.30
SELL
6 Feb 2019
Shames Richard S.
Chief Medical Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
26,758
-9%
2,778
$7.74
$21,505.50
SELL
6 Feb 2019
PATEL DINESH V PH D
President and CEO, Director, Officer
Protagonist Therapeutics, Inc
(PTGX)
367,396
-2%
10,909
$7.74
$84,409.95
SELL
6 Feb 2019
Liu David Y
Chief Scientific Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
37,007
-9%
3,821
$7.74
$29,561.55
SELL
17 May 2018
CANAAN X L.P.
10% Owner
Protagonist Therapeutics, Inc
(PTGX)
2,116,552
-1%
38,968
$6.09
$237,358.00
BUY
15 May 2018
Giraudo Bryan
Director
Protagonist Therapeutics, Inc
(PTGX)
10,000
+100%
10,000
$6.46
$64,566.00
SELL
14 May 2018
CANAAN X L.P.
10% Owner
Protagonist Therapeutics, Inc
(PTGX)
2,155,520
-7%
164,747
$6.42
$1,058,374.50
SELL
23 Mar 2018
CANAAN X L.P.
10% Owner
Protagonist Therapeutics, Inc
(PTGX)
2,320,267
-2%
59,950
$20.71
$1,241,324.60
SELL
20 Mar 2018
CANAAN X L.P.
10% Owner
Protagonist Therapeutics, Inc
(PTGX)
2,380,217
-1%
39,518
$20.61
$814,398.20
SELL
16 Mar 2018
CANAAN X L.P.
10% Owner
Protagonist Therapeutics, Inc
(PTGX)
2,419,735
-0%
20,365
$20.55
$418,508.25
SELL
13 Mar 2018
CANAAN X L.P.
10% Owner
Protagonist Therapeutics, Inc
(PTGX)
2,440,100
-0%
13,155
$20.66
$271,768.44
SELL
12 Mar 2018
Liu David Y
Chief Scientific Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
15,028
-18%
3,500
$21.29
$74,499.95
SELL
28 Feb 2018
Liu David Y
Chief Scientific Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
13,322
-6%
875
$20.00
$17,500.00
SELL
16 Jan 2018
Liu David Y
Chief Scientific Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
3,822
-18%
875
$20.00
$17,500.00
SELL
22 Dec 2017
Shames Richard S.
Chief Medical Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
0
-100%
3,529
$20.50
$72,344.50
SELL
21 Dec 2017
PATEL DINESH V PH D
President and CEO, Director, Officer
Protagonist Therapeutics, Inc
(PTGX)
190,437
-4%
8,210
$19.56
$160,569.55
SELL
20 Dec 2017
PATEL DINESH V PH D
President and CEO, Director, Officer
Protagonist Therapeutics, Inc
(PTGX)
190,437
-0%
1,790
$19.55
$34,987.34
SELL
18 Dec 2017
O'Neil Thomas P.
Chief Financial Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
0
-100%
8,000
$20.00
$160,000.00
SELL
18 Dec 2017
Liu David Y
Chief Scientific Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
3,822
-18%
875
$20.00
$17,500.00
SELL
30 Nov 2017
Liu David Y
Chief Scientific Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
3,822
-18%
875
$20.00
$17,500.00
SELL
13 Nov 2017
Liu David Y
Chief Scientific Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
3,822
-64%
7,000
$16.97
$118,761.31
SELL
5 Oct 2017
Shames Richard S.
Chief Medical Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
0
-100%
2,017
$19.00
$38,323.00
SELL
12 Sep 2017
Shames Richard S.
Chief Medical Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
0
-100%
3,687
$14.31
$52,752.86
SELL
29 Aug 2017
Shames Richard S.
Chief Medical Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
1,865
-44%
1,512
$17.00
$25,704.00
SELL
28 Aug 2017
Liu David Y
Chief Scientific Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
2,000
-63%
3,500
$15.00
$52,500.00
SELL
10 Jul 2017
Liu David Y
Chief Scientific Officer, Officer
Protagonist Therapeutics, Inc
(PTGX)
2,000
-63%
3,500
$12.68
$44,380.00
BUY
16 Aug 2016
JOHNSON & JOHNSON
10% Owner
Protagonist Therapeutics, Inc
(PTGX)
2,449,183
+31%
583,333
$12.00
$6,999,996.00
BUY
16 Aug 2016
LV Management Group, LLC
10% Owner
Protagonist Therapeutics, Inc
(PTGX)
2,099,482
+38%
583,333
$12.00
$6,999,996.00
BUY
16 Aug 2016
CANAAN X L.P.
Director, 10% Owner
Protagonist Therapeutics, Inc
(PTGX)
2,453,255
+31%
583,333
$12.00
$6,999,996.00
BUY
16 Aug 2016
Papanek Julie
Director
Protagonist Therapeutics, Inc
(PTGX)
2,453,255
+31%
583,333
$12.00
$6,999,996.00
BUY
16 Aug 2016
Shanafelt Armen
Director, 10% Owner
Protagonist Therapeutics, Inc
(PTGX)
2,099,482
+38%
583,333
$12.00
$6,999,996.00
Home